18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.
Saved in:
| Title: | 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer. |
|---|---|
| Authors: | Peterson LM; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington., Kurland BF; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania., Yan F; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington., Jiresova AN; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic., Gadi VK; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.; Clinical Research and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Specht JM; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington., Gralow JR; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington., Schubert EK; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania., Link JM; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and., Krohn KA; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and., Eary JF; Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland., Mankoff DA; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania., Linden HM; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington hmlinden@uw.edu. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Feb; Vol. 62 (2), pp. 184-190. Date of Electronic Publication: 2020 Jun 26. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32591490 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: <superscript>18</superscript>F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Peterson+LM%22">Peterson LM</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kurland+BF%22">Kurland BF</searchLink>; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Yan+F%22">Yan F</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Jiresova+AN%22">Jiresova AN</searchLink>; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Gadi+VK%22">Gadi VK</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.; Clinical Research and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Specht+JM%22">Specht JM</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Gralow+JR%22">Gralow JR</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Schubert+EK%22">Schubert EK</searchLink>; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Link+JM%22">Link JM</searchLink>; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and.<br /><searchLink fieldCode="AU" term="%22Krohn+KA%22">Krohn KA</searchLink>; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and.<br /><searchLink fieldCode="AU" term="%22Eary+JF%22">Eary JF</searchLink>; Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Mankoff+DA%22">Mankoff DA</searchLink>; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Linden+HM%22">Linden HM</searchLink>; Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington hmlinden@uw.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2021 Feb; Vol. 62 (2), pp. 184-190. <i>Date of Electronic Publication: </i>2020 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32591490 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.120.244459 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 184 Titles: – TitleFull: 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peterson LM – PersonEntity: Name: NameFull: Kurland BF – PersonEntity: Name: NameFull: Yan F – PersonEntity: Name: NameFull: Jiresova AN – PersonEntity: Name: NameFull: Gadi VK – PersonEntity: Name: NameFull: Specht JM – PersonEntity: Name: NameFull: Gralow JR – PersonEntity: Name: NameFull: Schubert EK – PersonEntity: Name: NameFull: Link JM – PersonEntity: Name: NameFull: Krohn KA – PersonEntity: Name: NameFull: Eary JF – PersonEntity: Name: NameFull: Mankoff DA – PersonEntity: Name: NameFull: Linden HM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 62 – Type: issue Value: 2 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |